RHAPSODY Phase 3 Study to Assess the Efficacy and Safety of Rilonacept Treatment in Subjects With Recurrent Pericarditis
Condition: Recurrent Pericarditis Interventions: Drug: Rilonacept; Drug: Placebo Sponsor: Kiniksa Pharmaceuticals, Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 9, 2018 Category: Research Source Type: clinical trials
